Latest drug discovery Stories
LOS ANGELES and SHANGHAI, Oct. 28.
Innovative software uses genetic information to find the best treatment options for cancer patients HOUSTON, Oct.
PCT-dependent Method Provides High Quality Mass Spectrometry-based Proteomic Analysis in Small Needle Biopsy Samples for the First Time, Offering Potential to Vastly Improve Drug Discovery and Design
Addition of Respected Clinical Trials Company Expands MPI Research Capabilities to Include Human Phase I Testing MATTAWAN, Mich., Oct.
Lawrence Livermore National Laboratory researchers recently published an article in PLOS ONE detailing the use of supercomputers to link proteins to drug side effects.
WHITE PLAINS, N.Y., Oct.
ENGLEWOOD, Colo., Oct. 20, 2014 /PRNewswire/ -- Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc.